WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of PPD, Inc. ("PPD" or the "Company") (NASDAQ: PPD) in connection with the proposed acquisition of the Company by Thermo Fisher Scientific Inc. (NYSE: TMO). Under the terms of the merger agreement, PPD shareholders will receive $47.50 in cash for each share of PPD common stock that they hold. The transaction is valued at approximately $17.4 billion .
If you own PPD, Inc. shares and wish to discuss this investigation or have any questions concerning this notice or your rights or interests, visit our website:
Or please contact:
Joshua Rubin, Esq.
1500 Broadway, 16 th Floor
New York , NY 10036
WeissLaw LLP is investigating whether PPD's board acted in the best interest of PPD's public shareholders in agreeing to the proposed transaction and whether all information regarding the process undertaken by the board and the valuation of the transaction will be fully and fairly disclosed to PPD's public shareholders.
WeissLaw LLP has litigated hundreds of stockholder class and derivative actions for violations of corporate and fiduciary duties. We have recovered over a billion dollars for defrauded clients and obtained important corporate governance relief in many of these cases. If you have information or would like legal advice concerning possible corporate wrongdoing (including insider trading, waste of corporate assets, accounting fraud, or materially misleading information), consumer fraud (including false advertising, defective products, or other deceptive business practices), or anti-trust violations, please email us at email@example.com
View original content to download multimedia: http://www.prnewswire.com/news-releases/shareholder-alert-weisslaw-llp-investigates-ppd-inc-301270194.html
SOURCE WeissLaw LLP